Yanong Daniel Wang

USPTO Granted Patents = 7 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 98(Granted Patents)

Location History:

Nanuet, NY (US) (2003 - 2008)
Warren, NJ (US) (2008 - 2021)

Company Filing History:

Wyeth Holdings Corporation

Years Active: 2003-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11116767 - 3,5-disubstituted pyrazoles useful as checkpoint kinase 1 (Chk1) inhibitors, and their preparations and applications (2021-09-14),

2. 7781591 - Substituted 3-cyanopyridines as protein kinase inhibitors (2010-08-24),

3. 7402703 - Stereoselective synthesis of (E)-vinylboronic esters via a Zr mediated hydroboration of alkynes (2008-07-22),

4. 7365197 - Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines (2008-04-29),

5. 6780996 - Process for the preparation of 7-substituted-3 quinolinecarbonitriles (2004-08-24),

6. 6689772 - 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors (2004-02-10),

7. 6521618 - 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors (2003-02-18),

Title: Biography of Yanong Daniel Wang

Introduction

Yanong Daniel Wang is an accomplished inventor based in Warren, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for therapeutic applications. With a total of 7 patents to his name, Wang's work has had a notable impact on drug discovery and development.

Latest Patents

Wang's latest patents include "3,5-disubstituted pyrazoles useful as checkpoint kinase 1 (Chk1) inhibitors, and their preparations and applications." This invention provides compounds that are potent inhibitors of Chk1, which play a crucial role in cancer therapy. Another significant patent is for "Substituted 3-cyanopyridines as protein kinase inhibitors," which outlines methods for treating autoimmune and inflammatory diseases through the administration of these compounds.

Career Highlights

Throughout his career, Wang has worked with prominent companies such as Wyeth and Wyeth Holdings Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Wang has collaborated with notable colleagues, including Diane H Boschelli and Dan Maarten Berger. These partnerships have contributed to the advancement of his research and the successful development of innovative therapeutic solutions.

Conclusion

Yanong Daniel Wang's contributions to the field of pharmaceuticals through his inventions and patents demonstrate

This text is generated by artificial intelligence and may not be accurate.